SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy.

Mahmod, M; Raman, B; Chan, K; Sivalokanathan, S; Smillie, RW; Samat, AHA; Ariga, R; Dass, S; Ormondroyd, E; Watkins, H; et al. Mahmod, M; Raman, B; Chan, K; Sivalokanathan, S; Smillie, RW; Samat, AHA; Ariga, R; Dass, S; Ormondroyd, E; Watkins, H; Neubauer, S (2022) Right ventricular function declines prior to left ventricular ejection fraction in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson, 24 (1). p. 36. ISSN 1532-429X https://doi.org/10.1186/s12968-022-00868-y
SGUL Authors: Sivalokanathan, Sanjay

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview

Abstract

BACKGROUND: The right ventricle (RV) in hypertrophic cardiomyopathy (HCM) tends to be neglected, as previous efforts have predominantly focused on examining the prognostic value of left ventricular (LV) abnormalities. The objectives of this study were to assess RV function in HCM, changes over time, and association with clinical outcomes. METHODS: Two hundred and ninety HCM patients with preserved LV ejection fraction (LVEF ≥ 55%) and 30 age- and sex-matched controls underwent cardiovascular magnetic resonance (CMR). All patients were followed up for clinical events for a median duration of 4.4 years. Sixty-three patients had a follow-up CMR undertaken at a median interval of 5.4 years. Main study measures and outcomes were RV function (RV ejection fraction (RVEF) and RV strain) at baseline, temporal changes in RV function over time and prognostic value of RV dysfunction for predicting cardiovascular outcomes in HCM. RESULTS: When compared to controls, HCM patients exhibited lower RV and LV peak global longitudinal systolic strains on feature-tracking analysis of cine images, while RVEF and LVEF were within the normal range. On follow-up CMR, both RV and LV strain parameters decreased over time. RVEF decreased at follow-up (65 ± 7% to 62 ± 7%, P < 0.001) but the change in LVEF was not significant (68 ± 10% to 66 ± 8%, P = 0.30). On clinical follow up, reduced RVEF was an independent predictor of non-sustained ventricular tachycardia (NSVT) [HR 1.10 (95% CI 1.06-1.15), P < 0.001] and composite cardiovascular events (NSVT, stroke, heart failure hospitalisation and cardiovascular death) [HR 1.07 (95% CI 1.03-1.10), P < 0.001]. RV longitudinal strain was an independent predictor of NSVT [HR 1.05 (95% CI 1.01-1.09), P = 0.029]. Patients with RVEF < 55% showed an increased risk of NSVT and composite cardiovascular events. In contrast, LVEF and LV global longitudinal strain were not predictive of such events on multivariable analysis. CONCLUSIONS: In HCM, RV function, including RV strain, and LV strain decrease over time despite preserved LVEF. Reduction in RV but not LV function is associated with adverse cardiovascular outcomes. Assessing RV function in early HCM disease might have a role in risk stratification to prevent future cardiovascular events.

Item Type: Article
Additional Information: © The Author(s) 2022. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Keywords: Cardiac magnetic resonance, Hypertrophic cardiomyopathy, Right ventricular function, Cardiomyopathy, Hypertrophic, Humans, Magnetic Resonance Imaging, Cine, Predictive Value of Tests, Stroke Volume, Ventricular Function, Left, Ventricular Function, Right, Humans, Cardiomyopathy, Hypertrophic, Magnetic Resonance Imaging, Cine, Stroke Volume, Predictive Value of Tests, Ventricular Function, Left, Ventricular Function, Right, Hypertrophic cardiomyopathy, Cardiac magnetic resonance, Right ventricular function, 1102 Cardiorespiratory Medicine and Haematology, Nuclear Medicine & Medical Imaging
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: J Cardiovasc Magn Reson
ISSN: 1532-429X
Language: eng
Dates:
DateEvent
13 June 2022Published
19 May 2022Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
FS/12/32/29559British Heart Foundationhttp://dx.doi.org/10.13039/501100000274
PubMed ID: 35692049
Web of Science ID: WOS:000809664700001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/114496
Publisher's version: https://doi.org/10.1186/s12968-022-00868-y

Actions (login required)

Edit Item Edit Item